Flu season fills chairs that unanswered phones never book

The cost of flu season that never appears on a dashboard is the inbound call that dies in a busy signal. CDC estimates tens of millions of flu-related medical visits in a high-severity U.S. season, and practice leaders already rank phone access among top 2026 priorities. Capacity is whether the schedule can absorb demand that is trying to reach you.

The invisible cost is demand you never logged

Most practices can tell you how many flu vaccine doses they ordered and how many respiratory visits they completed last winter. Far fewer can tell you how many people tried to schedule, reschedule, ask about symptoms that needed triage routing, or confirm a same-day slot — and never got through. That asymmetry is the create-need problem: the cost is real, but it is invisible because the missed attempt leaves no row in the schedule report.

Flu season is the stress test that makes the gap loud. Respiratory demand arrives in clusters. Parents call after school. Older adults call when symptoms worsen overnight. Working adults call during lunch and again after 5 p.m. If the only answer is a hold queue that collapses into voicemail, the practice experiences the season as “busy” while the community experiences it as “unreachable.” The empty chair tomorrow is often yesterday’s unanswered ring.

This is not an argument that every flu-like illness needs an in-person visit. CDC’s own 2025–2026 season guidance continues to emphasize vaccination for people 6 months and older and prompt care for people at higher risk of complications. The operational point is narrower: when tens of millions of medical visits are associated with flu in a high-severity year, a non-trivial share of that ambulatory load has to pass through a phone, portal, or messaging channel before it becomes a completed encounter. If that channel fails first, capacity planning based only on completed visits systematically understates true demand.

What CDC actually measured in a high-severity season

CDC’s end-of-season summary for 2024–2025 is the cleanest single snapshot available for the most recent completed season. Based on data from October 1, 2024, through April 30, 2025, CDC estimates:

• 51 million people were sick with flu,
• 23 million people visited a healthcare provider in an outpatient setting for flu illness,
• 710,000 people had a flu-related hospitalization, and
• 45,000 flu-related deaths occurred.

CDC classified the season as high severity across all ages — the first high-severity season since 2017–2018. Estimated illnesses and medical visits were higher than that prior high-severity season; hospitalizations matched 2017–2018; deaths were lower than 2017–2018 but still elevated versus most seasons back to 2010–2011. Adults 65 and older accounted for 57% of hospitalizations and 71% of deaths in the estimate — which is why primary care, urgent care, and hospital overflow feel the season at different intensities at once.

Vaccination still moved the needle. CDC estimates flu vaccination prevented about 10 million illnesses, 5 million medical visits, 180,000 hospitalizations, and 12,000 deaths during 2024–2025. That is not a marketing claim; it is the agency’s own burden-prevented model. For a practice, the implication is double: vaccination campaigns reduce some visit demand, and the remaining demand is still large enough to swamp a phone system that was already marginal in September.

The multi-year frame matters because “last year was bad” can sound like an anomaly. On CDC’s About Estimated Flu Burden page, the agency states that between 2010 and 2025 flu resulted in an estimated 9.4 million–51 million illnesses, 120,000–710,000 hospitalizations, and 6,300–52,000 deaths annually. In other words, 2024–2025 sits at the top of the illness and hospitalization ranges — but even a moderate season still produces medical-visit volume that competes with routine primary care.

CDC’s activity summary for 2024–25 adds operational texture. Clinical laboratories reporting to CDC tested nearly 4 million respiratory specimens; 12.3% tested positive for influenza. National weekly positivity peaked at 31.6% in the week ending February 1, 2025 — the highest peak percentage in nine seasons. Activity began rising in mid-November and peaked in early February. That calendar is the map of when front desks get crushed: not evenly across winter, but in a rising wave that rewards practices that planned phone capacity before Thanksgiving rather than after the first week of jammed lines.

Severity is a system-load signal, not a front-desk rumor

CDC does not classify severity by how many people complained on social media. The in-season severity assessment uses three surveillance indicators: outpatient influenza-like illness (ILI) visits, flu-related hospitalization rates, and the percent of deaths coded as flu. Weekly values are compared with intensity thresholds derived from past seasons (roughly the 50th, 90th, and 98th percentiles). Low, moderate, high, or very high classifications follow from those crossings; the overall weekly label blends the three indicators.

For practice operations, that methodology is useful because it translates “the season feels heavy” into a public signal you can watch without reinventing epidemiology. When ILI outpatient visits are climbing, your phone is not inventing demand — it is receiving a share of a national outpatient surge. When hospitalization rates rise, same-day and next-day primary care requests often rise with them as people try to avoid the emergency department or seek antivirals after a home test. CDC’s preliminary 2025–2026 burden page also reminds readers that in-season estimates are ranges updated weekly, and that past end-of-season hospitalization estimates from 2010–2025 ranged from 120,000 to 710,000 — the same band that frames how much hospital overflow can back-pressure ambulatory access.

Manufacturers projected supplying as many as 154 million doses of flu vaccine for 2025–2026, according to CDC’s season page. Vaccination clinics, walk-in demand, and questions about which formulation is appropriate all add non-visit phone volume on top of illness-driven calls. A practice that only counts “flu visits completed” will miss the administrative layer that still consumes the same human ears.

Phone access is already on the 2026 priority list

You do not need a flu-specific phone survey to know that medical groups treat the telephone as an access problem. In a December 9, 2025 MGMA Stat poll with 236 applicable responses, practice leaders split their top 2026 patient-access focus across four nearly equal priorities: no-shows (27%), online scheduling (24%), phone access (22%), and wait times (21%). Phone access is not a niche concern for megagroups; it is one of the four fronts leaders say they are organizing around.

MGMA’s write-up is explicit that better phone access shows up in patient-experience scores around “getting care when needed,” and that it also fills open slots when staff stop missing calls from people ready to schedule. That sentence is the bridge between flu epidemiology and practice math: during a respiratory peak, the people ready to schedule include those seeking vaccine appointments, those needing same-day evaluation, and those who need to move a chronic-care visit because they are now sick. If the line fails, the schedule does not merely stay full — it stays full of the wrong mix, with urgent demand bouncing elsewhere and preventive slots going empty when someone could have rebooked overnight.

The same poll’s no-show focus is not a separate story. Leaders fighting missed visits are doubling down on reminders and confirmation texts — which still depend on a channel that can complete the loop when someone needs to move a visit because they now have fever, cough, or childcare failure. Flu season raises both the volume of new demand and the volatility of already-booked demand. A practice that measures only one of those streams will keep being surprised by empty chairs that were full on paper at 8 a.m.

For U.S. practices already thinking about after-hours coverage, this seasonal spike is the amplifier of the quieter year-round problem described in after-hours calls as an invisible practice cost. Flu does not invent the phone gap; it makes the cost of not measuring it impossible to ignore.

What closing the gap looks like without adding clinicians

Closing the gap does not mean diagnosing flu on an automated line. It means treating inbound access as capacity infrastructure. A first-line voice and messaging agent — framed generically, without vendor theater — can answer when the desk is saturated, book or reschedule against real availability, confirm tomorrow’s slots when people wake up sick, capture a callback reason, and escalate anything that sounds urgent to a human pathway with context. Clinical judgment stays with clinicians. The schedule stops discovering yesterday’s demand only after the slot has already gone empty.

That design also has to sit inside the same privacy and consent discipline as daytime reminders. Automated appointment reminders and confirmation workflows for U.S. practices live next to HIPAA expectations; the operational detail is covered in our note on HIPAA-aware voice appointment reminders. A seasonal surge is not an excuse to loosen those rules — it is a reason to make the compliant channel actually reachable.

If you want a rough sense of how missed inbound demand translates into operational loss for your own panel, Arbol’s Spanish-language missed-calls calculator can help you stress-test assumptions — note that the tool UI is currently Spanish-first; an English-labeled twin is still a gap. The United States market page at /en/united-states/ is the landing that connects this access problem to how an AI agent is scoped for U.S. practices.

What your practice can do this week

You do not need a new EHR module to start. You need a measurement habit timed to the respiratory calendar CDC already publishes.

Flu season will keep returning. CDC’s 2010–2025 ranges guarantee that. The practices that stop treating unanswered phones as a soft courtesy problem will be the ones whose schedules still match community demand when positivity rates spike again. The invisible cost becomes visible the moment you decide to count the rings that never became rows.